POC検査装置の世界市場分析・予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 12
1.2 List of Figures 16
2 Introduction 18
2.1 Catalyst 18
2.2 Related Reports 18
3 Industry Overview 19
3.1 POC Diagnostics Overview 19
3.2 Test Trends 21
3.2.1 Cardiac Markers POC Testing 21
3.2.2 Female Fertility and Pregnancy POC Testing 24
3.3 Mergers, Acquisitions, and Key Partnerships 29
4 Unmet Needs 33
4.1 Detection of Multiple Analytes 33
4.2 Sensitivity of Lateral Flow Technology 33
4.3 Analytical Quality 35
4.4 Markers for Myocardial Ischemia 35
4.5 Data Management 36
4.6 POC Diagnostics to Reduce Usage of Antibiotics 37
4.7 Cost-Effectiveness and Reimbursement 38
4.8 Gap between Physicians and Manufacturers 39
5 Market Drivers and Barriers 40
5.1 Drivers 40
5.1.1 Fast Turnaround Time 40
5.1.2 POC Molecular Testing Driving Infectious Disease POCT 40
5.1.3 Increasing Adoption of Cardiac Marker POCT 41
5.1.4 Expansion POC Testing Menu 42
5.1.5 Expansion of the Home-Testing Market 43
5.1.6 CLIA Waived Status for POCT 43
5.1.7 Rising Prevalence of Diseases 44
5.2 Barriers 44
5.2.1 Management of POCT 44
5.2.2 Competition with Laboratory Tests 45
5.2.3 Regulatory Compliance 46
5.2.4 Medical Device Excise Tax 47
6 Competitive Assessment 48
6.1 Company Share Analysis 48
6.1.1 Global 48
6.1.2 US 49
6.1.3 Europe 50
6.1.4 Asia-Pacific 51
6.2 Trends in Corporate Strategy 52
6.3 Major Players 53
6.3.1 Abbott Diagnostics 53
6.3.2 Akers Bioscience 56
6.3.3 Alere 59
6.3.4 Beckman Coulter 64
6.3.5 BioMerieux 66
6.3.6 Chembio Diagnostics 69
6.3.7 EKF Diagnostics 72
6.3.8 Meridian Bioscience 75
6.3.9 OraSure Technologies 79
6.3.10 Quidel 82
6.3.11 Radiometer Medical 86
6.3.12 Response Biomedical 89
6.3.13 Roche Diagnostics 93
6.3.14 Siemens Healthcare 97
6.3.15 Trinity Biotech 100
6.3.16 Other Companies 104
7 Pipeline Assessment 116
7.1 Overview 116
7.2 Pipeline Profiles 117
7.2.1 Cardiac Markers POCT 117
7.2.2 Female Fertility and Pregnancy POCT 118
7.2.3 Hematology POCT 118
7.2.4 Infectious Disease POCT 119
7.2.5 Immunochemistry POCT Analyzers 125
8 Market Outlook 126
8.1 By Market Segment 126
8.1.1 Global Overview 126
8.1.2 Cardiac Markers POCT 128
8.1.3 Female Fertility and Pregnancy POCT 130
8.1.4 Hematology POCT 132
8.1.5 Infectious Disease POCT 133
8.1.6 Immunochemistry POCT Analyzers 134
8.2 By Geography 136
8.2.1 Global Overview 136
8.2.2 US 139
8.2.3 France 141
8.2.4 Germany 144
8.2.5 Italy 146
8.2.6 Spain 150
8.2.7 UK 152
8.2.8 Japan 156
8.2.9 China 158
8.2.10 India 161
8.2.11 Brazil 164
9 Appendix 168
9.1 Bibliography 168
9.2 Abbreviations 172
9.3 Report Methodology 177
9.3.1 Overview 177
9.3.2 Coverage 177
9.3.3 Secondary Research 177
9.3.4 Forecasting Methodology 178
9.3.5 Primary Research — Key Opinion Leader Interviews 179
9.3.6 Primary Research – Physician and Industry Interviews 180
9.3.7 Expert Panel Validation 181
9.4 Physicians and Specialists Included in This Study 182
9.5 About the Authors 183
9.5.1 Analysts 183
9.5.2 Tyler Fletcher, Global Head of Medical Devices 184
9.6 About MediPoint 185
9.7 About GlobalData 185
9.8 Disclaimer 185